產品詳情
查看大圖

  • 產品名稱：CCL-228 SW480 人結腸腺癌細胞

  • 產品型號：CCL-228
  • 產品廠商：其它品牌
  • 產品文檔：
你添加了1件商品 查看購物車
簡單介紹：
簡單介紹 CCL-228 SW480 人結腸腺癌細胞， ATCC 細胞|細胞係|細胞株|腫瘤細胞|細胞|貼壁細胞|懸浮細胞；細胞庫管理規範，提供的細胞株背景清楚，提供參考文獻和**培養條件！
詳情介紹：

CCL-228 SW480 人結腸腺癌細胞 的詳細介紹
CCL-228 SW480 人結腸腺癌細胞
ATCC® Number: CCL-228™     Price:  
Designations: SW480 [SW-480]
Depositors:  A Leibovitz
Biosafety Level: 1
Shipped: frozen
Medium & Serum: See Propagation
Growth Properties: adherent
Organism: Homo sapiens (human)
Morphology: epithelial
CCL-228 SW480 人結腸腺癌細胞
Source: Organ: colon 
Tumor Stage: Dukes' type B 
Disease: colorectal adenocarcinoma
Cellular Products: carcinoembryonic antigen (CEA) 0.7 ng/10 exp6 cells/10 days; keratin; transforming growth factor beta
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
 
Applications: transfection host (Nucleofection technology from Lonza
Roche FuGENE® Transfection Reagents)
Receptors: epidermal growth factor (EGF)
Virus Susceptibility: Human immunodeficiency virus 1
Tumorigenic: Yes
Reverse Transcript: negative
Oncogene: myc +; myb + ; ras +; fos +; sis +; p53 +; abl -; ros -; src -
Antigen Expression: HLA A2, B8, B17; blood type A; Rh+
DNA Profile (STR): Amelogenin: X 
CSF1PO: 13,14 
D13S317: 12 
D16S539: 13 
D5S818: 13 
D7S820: 8 
THO1: 8 
TPOX: 11 
vWA: 16
Cytogenetic Analysis: The stemline chromosome number is hypotriploid and 11-12 marker chromosomes were common. Both double minutes and dicentrics were observed in 8% of each metaphase examined.
Isoenzymes: ES-D, 1 
G6PD, B 
PEP-D, 1 
PGD, A 
PGM1, 2 
PGM3, 1
Age: 50 years
Gender: male
Ethnicity: Caucasian
Comments: SW480 was established from a primary adenocarcinoma of the colon. [23025] 
A cell line established from a lymph node metastasis taken from the same patient one year later is available (see ATCC CCL-227). [23025] 
The line is negative for CSAp (CSAp-) and colon antigen 3. 
The cells are positive for keratin by immunoperoxidase staining. 
There is a G -> A mutation in codon 273 of the p53 gene resulting in an Arg -> His substitution and a C -> T mutation in codon 309 resulting in a Pro -> Ser substitution. [22870] [23322] 
The cells express elevated levels of p53 protein. [23322] 
The line is positive for expression of c-myc, K-ras, H-ras, N-ras, myb, sis and fos oncogenes. [22861] 
N-myc oncogene expression was not detected. [22861] 
Matrilysin, a metalloproteinase associated with tumor invasiveness, is not expressed. [49853] 
The cells have been reported to produce GM-CSF. [23114] 
This line has a mutation in codon 12 of the ras protooncogene, and can be used as a positive control for PCR assays of mutation in this codon.
Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Leibovitz's L-15 Medium, Catalog No. 30-2008. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Atmosphere: air, **** 
Temperature: 37.0°C
Subculturing: Protocol:
  1. Remove and discard culture medium.
  2. Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum which contains trypsin inhibitor.
  3. Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
    Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
  4. Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
  5. Add appropriate aliquots of the cell suspension to new culture vessels.
  6. Incubate cultures at 37°C. without CO2.

Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:8 is recommended 
Medium Renewal: 1 to 2 times per week
Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO 
Storage temperature: liquid nitrogen vapor phase
Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2008
recommended serum:ATCC 30-2020
derived from same individual:ATCC CCL-227
References: 22536: Fogh J, et al. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J. Natl. Cancer Inst. 58: 209-214, 1977. PubMed: 833871
22539: Fogh J, et al. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J. Natl. Cancer Inst. 59: 221-226, 1977. PubMed: 327080
22545: Lelbovitz A, et al. Detection and analysis of a glucose 6-phosphate dehydrogenase phenotype B cell line contamination. J. Natl. Cancer Inst. 63: 635-645, 1979. PubMed: 288927
22564: Adachi A, et al. Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus. J. Virol. 61: 209-213, 1987. PubMed: 3640832
22794: Schroy PC, et al. Detection of p21ras mutations in colorectal adenomas and carcinomas by enzyme-linked immunosorbent assay. Cancer 76: 201-209, 1995. PubMed: 8625092
22861: Trainer DL, et al. Biological characterization and oncogene expression in human colorectal carcinoma cell lines. Int. J. Cancer 41: 287-296, 1988. PubMed: 3338874

滬公網安備 31010902002433號